Petros Pharmaceuticals, Inc. (PTPI)
USD 0.05
(-3.36%)
USD 0.05
(-3.36%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 6.85 Million USD | -20.73% |
| 2022 | 8.65 Million USD | 2035.9% |
| 2021 | 405.01 Thousand USD | -23.67% |
| 2020 | 530.59 Thousand USD | -92.49% |
| 2019 | 7.06 Million USD | -74.68% |
| 2018 | 27.89 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 5.69 Million USD | -11.81% |
| 2024 Q1 | 6.46 Million USD | -5.79% |
| 2023 Q1 | 8.23 Million USD | -4.78% |
| 2023 FY | 6.85 Million USD | -20.73% |
| 2023 Q3 | 7.4 Million USD | -5.34% |
| 2023 Q2 | 7.81 Million USD | -5.1% |
| 2023 Q4 | 6.99 Million USD | -5.47% |
| 2022 Q3 | 9.05 Million USD | -4.22% |
| 2022 Q2 | 9.45 Million USD | -3.99% |
| 2022 FY | 8.65 Million USD | 2035.9% |
| 2022 Q1 | 9.84 Million USD | 2331.7% |
| 2022 Q4 | 8.65 Million USD | -4.48% |
| 2021 Q1 | 500.51 Thousand USD | -5.67% |
| 2021 FY | 405.01 Thousand USD | -23.67% |
| 2021 Q4 | 405.01 Thousand USD | -7.48% |
| 2021 Q3 | 437.74 Thousand USD | -6.78% |
| 2021 Q2 | 469.57 Thousand USD | -6.18% |
| 2020 Q4 | 530.59 Thousand USD | -5.14% |
| 2020 FY | 530.59 Thousand USD | -92.49% |
| 2020 Q3 | 559.33 Thousand USD | -4.68% |
| 2020 Q2 | 586.82 Thousand USD | -93.29% |
| 2020 Q1 | 8.74 Million USD | 13.52% |
| 2019 Q4 | 7.7 Million USD | 0.0% |
| 2019 FY | 7.06 Million USD | -74.68% |
| 2019 Q1 | - USD | 0.0% |
| 2018 FY | 27.89 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 98.6% |
| Embecta Corp. | 1.62 Billion USD | 99.578% |
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | 97.786% |
| Dynavax Technologies Corporation | 252.41 Million USD | 97.283% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | 98.633% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 98.665% |
| PainReform Ltd. | 30 Thousand USD | -22757.88% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | 92.471% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -1172.156% |
| SCYNEXIS, Inc. | 12.15 Million USD | 43.603% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -5754.54% |
| Cosmos Health Inc. | 3.03 Million USD | -125.917% |
| Journey Medical Corporation | 14.62 Million USD | 53.102% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -1172.156% |
| Safety Shot Inc | 304.9 Thousand USD | -2149.002% |
| Alpha Teknova, Inc. | 13.25 Million USD | 48.25% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | 48.541% |
| Bright Green Corporation | 201.78 Thousand USD | -3298.385% |
| Procaps Group, S.A. | 28.41 Million USD | 75.863% |
| Theratechnologies Inc. | 51.26 Million USD | 86.623% |
| Harrow Health, Inc. | 183.17 Million USD | 96.256% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -7782.028% |
| Biofrontera Inc. | 804 Thousand USD | -752.906% |
| DURECT Corporation | 2.7 Million USD | -153.788% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | 79.343% |
| Cronos Group Inc. | 1.55 Million USD | -339.857% |
| OptiNose, Inc. | 611 Thousand USD | -1022.318% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 98.624% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | 79.943% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -1407.113% |
| Organogenesis Holdings Inc. | 60.74 Million USD | 88.711% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | 46.36% |
| Radius Health, Inc. | 339.66 Million USD | 97.981% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | 33.151% |
| Phibro Animal Health Corporation | 458.28 Million USD | 98.504% |
| Procaps Group S.A. | 28.41 Million USD | 75.863% |
| Alvotech | 1.02 Billion USD | 99.333% |
| TherapeuticsMD, Inc. | 6.53 Million USD | -4.981% |
| Viatris Inc. | 16.18 Billion USD | 99.958% |
| Rockwell Medical, Inc. | 8.29 Million USD | 17.311% |
| Aytu BioPharma, Inc. | 10.87 Million USD | 36.955% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -1940.937% |
| Tilray Brands, Inc. | 287.93 Million USD | 97.618% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | 94.31% |
| Shineco, Inc. | 10.01 Million USD | 31.545% |
| PetIQ, Inc. | 437.82 Million USD | 98.434% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 210 Thousand USD | -3165.411% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | 97.345% |
| Alimera Sciences, Inc. | 64.48 Million USD | 89.367% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 38.51 Million USD | 82.195% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -4976.182% |
| Clever Leaves Holdings Inc. | 720 Thousand USD | -852.412% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -30398.861% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | 79.068% |
| Hempacco Co., Inc. | 5.93 Million USD | -15.619% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.02 Billion USD | 99.333% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | 87.802% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 98.887% |
| Currenc Group, Inc. | 2.5 Million USD | -173.532% |
| Kamada Ltd. | 7.43 Million USD | 7.806% |
| Indivior PLC | 235.66 Million USD | 97.09% |
| Evoke Pharma, Inc. | 5 Million USD | -37.147% |
| Flora Growth Corp. | 942 Thousand USD | -627.958% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -30398.861% |
| Evolus, Inc. | 120.35 Million USD | 94.303% |
| HUTCHMED (China) Limited | 48.18 Million USD | 85.77% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 98.836% |
| Akanda Corp. | 2.49 Million USD | -174.607% |